University of Colorado Cancer Center Study uncovers discrepant decision-making for use of 21-gene assay in women with cancer: Testing occurs in high-risk population, despite current evidence Non-concordance with NCCN Guidelines® recommendations Racial and socio-economic disparities found in testing use The 21-gene recurrence score (RS) assay, Oncotype DX™ (ODx), determines a score that estimates the likelihood of distant recurrence of disease …
Link between air pollution and breast cancer discovered
From: figo.org (International Federation of Gynecology and Obstetrics) Women living in areas that experience high levels of pollution could be at a higher risk of breast cancer, according to a new study. Research has suggested that increased exposure to soot particles could lead to denser breast tissue, which is one of the strongest risk factors linked to breast cancer. Those …
Dealing With the Side Effects of Breast Cancer Treatment
View PostDo I Need To Change My Breast Implants Every 10 Years?
By: Jonathan Kaplan, MD / San Francisco, CA From: plasticsurgery.org The short answer is probably not. So if it’s not really necessary, why is it that every patient that researches breast augmentation has come across the magic number of 10? The need to replace breast implants (saline or silicone) every 10 years is based on factual data that has since …
Vaccine may prevent progression of DCIS to breast cancer
From: healio.com Researchers at Mayo Clinic received a $3.7 million grant from the U.S. Department of Defense to test a vaccine designed to establish lifelong immunity against the development of breast cancer in women with ductal carcinoma in situ. No methods exist to detect which of the 35% of ductal carcinoma in situ (DCIS) cases will progress to cancer if …
Slender women have a HIGHER risk of breast cancer, study warns
By: Mia De Graaf From: dailymail.co.uk Slender women have a higher risk of developing breast cancer, a new study warns. Scientists evaluated fat tissue from the breast and blood samples of 72 women with normal body-mass indices – less than 25. They found that 40 percent of them had ominous inflammation in their breast fat tissue. The reason, they believe, …
Trial Of Immune Drug In Breast Cancer Points To Need For Biomarkers
By: Elaine Schattner From: forbes.com At first glance, results with a powerful immune agent in breast cancer appear negative. In an early-phase clinical trial, only 10% of patients with metastatic disease responded to atezolizumab (Tecentriq). Yet for those few women who did respond, the benefit was dramatic. Among 112 women with evaluable, advanced disease, 11 have experienced durable responses lasting …
An Easter Message for the Cancer Community
View PostImmunotherapy May Treat This Deadly Breast Cancer
By: Alice Park From: time.com Triple negative breast cancer is one of the most difficult types of cancer to treat. It lacks proteins that can attract powerful anti-cancer and hormone drugs, so people diagnosed with the disease have to rely almost exclusively on chemotherapy. But in a new presentation at the annual American Association for Cancer Research meeting, researchers say …
Scientists identify new gene that drives drug resistance in breast cancer
From: news-medical.net SCIENTISTS in Salford, UK, have identified a gene which is ‘revving the engine of cancer’ against the world’s most common breast cancer drug. For reasons unknown, 50% of patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment. In a paper published this week in the journal Oncotarget, biochemists tested a …